ABT-639 is a novel, peripherally acting, selective T-type Ca2+ channel blocker.
Naloxegol is a CYP3A4 enzyme inhibitor, is a peripherally-selective opioid antagonist, for the treatment of opioid-induced constipation.
Naloxegol oxalate is a CYP3A4 enzyme inhibitor, is a peripherally-selective opioid antagonist, for the treatment of opioid-induced constipation.
Potent, selective blocker of Kir1.1 channels. Tertiapin Q (ab120432) derivative.
Abcam优势服务 货号:ab120484,Potent, selective blocker of Kir1.1 channels. Tertiapin Q (ab120432) derivative.
Abcam优势服务 货号:ab120379,Selective blocker of the high-conductance, Ca2+-activated K+ channel
Abcam优势服务 货号:ab145993,Potassium-sparing diuretic. Epithelial sodium channel (eNaC) blocker. Selective T-type calcium channel blocker. Also inhibits urokinase-type plasminogen activator (uPA) receptor.
Abcam优势服务 货号:ab141507,Selective GluR2 lacking AMPA receptor blocker. Open channel blocker.
A Selective and Potent Opener of KCa2.2 and KCa2.3 Channels and a Blocker of TRPM7 Channel
Potent, selective ASIC1a blocker
Non-selective Na+ / Ca2+ channel blocker
Selective NaV1.8 channel blocker
本产品信息由（厦门慧嘉生物科技有限公司）为您提供，内容包括（ABT-639 is a novel, peripherally acting, selective T-type Ca2+ channel blocker.）的品牌、型号、技术参数、详细介绍等；如果您想了解更多关于（ABT-639 is a novel, peripherally acting, selective T-type Ca2+ channel blocker.）的信息，请直接联系供应商，给供应商留言。若当前页面内容侵犯到您的权益，请及时告知我们，我们将马上修改或删除。
沪公网安备 31011502008050号
